In fact, targeted treatment against TNF-α has been initiated in various autoimmune diseases, such as TNF-α inhibitors significantly improving clinical symptoms in inflammatory bowel disease, rheumatoid arthritis, and psoriasis [33–35]. This evidence concerns the gene TNF and inflammatory bowel disease.